Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Carcinosarcoma × niraparib × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 65 Fallopian Tube Neoplasms 17 Breast Neoplasms 7 Endometrial Neoplasms 6 Carcinoma, Ovarian Epithelial 5 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Uterine Neoplasms 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Sarcoma 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Recurrence 1 Prostatic Diseases 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Platinum-resistant Ovarian Cancer 1 Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1 Ovarian Diseases 1 Ovarian Carcinosarcoma 1 Neutropenia 1 Nausea 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡